FindTrial
Sign In

Assessment of Antiplatelet resistance like aspirin and clopidogrel in patients with Ischemic stroke using Thromboelastogram Platelet Mapping

Assessment of Antiplatelet resistance in ischemic stroke patients using Thromboelastogram Platelet Mapping - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/07/055555
Enrollment
60
Registered
2023-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G938- Other specified disorders of brain

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Gleneagles Global Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients above 18 years of age 2.Patients admitted to ICU with diagnosis of ischemic stroke 3.Patients willing to participate in study

Exclusion criteria

Exclusion criteria: 1.Patients admitted to ICU without ischemic stroke 2.Patients with history of intravenous thrombolysis 3.Patients who were taking anticoagulants 4.Patients with platelet count less than 1,20,000cells/mm3 5.Patients with pre-existing bleeding disorders 6.Patients not willing to participate in the study

Design outcomes

Primary

MeasureTime frame
To evaluate proportion of ischemic stroke patients demonstrating antiplatelet resistance Timepoint: After 48hrs of initiation of antiplatelet therapy—

Secondary

MeasureTime frame
To evaluate maximal amplitude (MA) of ADP, AA, A & CK by TEG-PM.Timepoint: After 48hrs of initiation of antiplatelet therapy—

Countries

India

Contacts

Public ContactVadlapudi Sai krupa

Gleneagles Global Hospital

mohana.stan02@gmail.com7021366538

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026